Phase 2 trial Phase II Trial of Interleukin-1 Receptor Antagonist in Intracerebral Hemorrhage: BLOcking the Cytokine IL-1 in ICH to reduce edema at 72 h is not recruiting yet [146]. Here, IL1B is linked to hemorrhage.